S-Equol mitigates motivational deficits and dysregulation associated with HIV-1

Motivational deficits (e.g., apathy) and dysregulation (e.g., addiction) in HIV-1 seropositive individuals, despite treatment with combination antiretroviral therapy, necessitates the development of innovative adjunctive therapeutics. S-Equol (SE), a selective estrogen receptor β agonist, has been i...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaurin, Kristen A., Bertrand, Sarah J., Illenberger, Jessica M., Harrod, Steven B., Mactutus, Charles F., Booze, Rosemarie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178385/
https://www.ncbi.nlm.nih.gov/pubmed/34088932
http://dx.doi.org/10.1038/s41598-021-91240-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178385/
https://www.ncbi.nlm.nih.gov/pubmed/34088932
http://dx.doi.org/10.1038/s41598-021-91240-0

Ejemplares similares